Direkt zum Inhalt
Merck

Fortfahren mit

06-864

Anti-FLIP Antibody, CT

Upstate®, from rabbit

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
PackungsgrößeSKUVerfügbarkeitPreis
200 μg
Warenkorb auf Verfügbarkeit prüfen
€ 439,00

Über diesen Artikel

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
WB
Citations:
9

€ 439,00


Warenkorb auf Verfügbarkeit prüfen

Großbestellung anfragen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


biological source

rabbit

Quality Level

conjugate

unconjugated

antibody form

purified antibody

antibody product type

primary antibodies

clone

polyclonal

species reactivity

human, mouse, rat

manufacturer/tradename

Upstate®

technique(s)

western blot: suitable

isotype

IgG

NCBI accession no.

UniProt accession no.

shipped in

dry ice

target post-translational modification

unmodified

Gene Information

human ... CFLAR(8837)

General description

55kDa

Immunogen

peptide corresponding to amino acids 447-464 [NGYMYDWNSRVSAKEKYY] of human FLIP

Application

Detect FLIP using this Anti-FLIP Antibody, CT validated for use in WB.
Research Category
Apoptosis & Cancer
Research Sub Category
Apoptosis - Additional

Biochem/physiol Actions

long form of FLIP

Physical form

Format: Purified
PBS, pH 7.4, 0.02% sodium azide before the addition of glycerol to 30%
Protein A chromatography

Preparation Note

2 years at -20°C

Analysis Note

Control
Positive Antigen Control: Catalog #12-303, Jurkat cell lysate.
routinely evaluated by immunoblot on Jurkat, A431, Raji, 3T3, CTLL, PC12 or L6 RIPA cell lysates

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
06-50207-73207-337
clone

polyclonal

clone

polyclonal

clone

polyclonal

clone

polyclonal

conjugate

unconjugated

conjugate

-

conjugate

unconjugated

conjugate

unconjugated

antibody form

purified antibody

antibody form

purified immunoglobulin

antibody form

purified antibody

antibody form

purified immunoglobulin

biological source

rabbit

biological source

rabbit

biological source

rabbit

biological source

rabbit

species reactivity

human, mouse, rat

species reactivity

human, mouse

species reactivity

human, mouse

species reactivity

mouse, human

Gene Information

human ... CFLAR(8837)

Gene Information

human ... STAT2(6773)

Gene Information

human ... HDAC6(10013)

Gene Information

human ... SOS1(6654)


Still not finding the right product?

Probieren Sie unser Produkt-Auswahlhilfe, um Ihre Auswahl einzugrenzen


Lagerklasse

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Predisposition to apoptosis in keratin 8-null liver is related to inactivation of NF-?B and SAPKs but not decreased c-Flip.
Lee, J; Jang, KH; Kim, H; Lim, Y; Kim, S; Yoon, HN; Chung, IK; Roth, J; Ku, NO
Biology Open null
Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells.
Vesely, DL; Hoffman, B; Liebermann, DA
Oncogene null
Rongbin Ge et al.
Oncotarget, 6(30), 28973-28987 (2015-09-12)
Metformin has emerged as a potential anticancer agent. Here, we demonstrate that metformin plays an anti-tumor role via repressing N-cadherin, independent of AMPK, in wild-type N-cadherin cancer cells. Ectopic-expression of N-cadherin develops metformin-resistant cancer cells, while suppression of N-cadherin sensitizes



Questions

Reviews

No rating value

Active Filters